Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews · Gut

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 1 · 100%

Maintenance of clinical remission · people with Crohn's disease

Vedolizumab leads to higher maintenance of clinical remission (52–60 weeks) compared with placebo (high certainty).

1 finding from 1 review

Vedolizumab for induction and maintenance of remission in Crohn's disease 2023 · Cochrane Headline outcomes only
RR 1.52 [1.24, 1.87]
3 studies · 894 participants
High